Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
5.72
-0.02 (-0.35%)
At close: Jul 26, 2024, 4:00 PM
5.75
+0.03 (0.52%)
After-hours: Jul 26, 2024, 5:37 PM EDT
Eagle Pharmaceuticals Market Cap
Eagle Pharmaceuticals has a market cap or net worth of $74.29 million as of July 26, 2024. Its market cap has decreased by -68.38% in one year.
Market Cap
74.29M
Enterprise Value
129.12M
1-Year Change
-68.38%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from $178.40M to $74.29M, a decrease of -58.36%. That is a compound annual growth rate of -8.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 74.50M | 9.72% |
Dec 29, 2023 | 67.90M | -82.16% |
Dec 30, 2022 | 380.50M | -42.14% |
Dec 31, 2021 | 657.60M | 8.37% |
Dec 31, 2020 | 606.80M | -26.13% |
Dec 31, 2019 | 821.40M | 36.69% |
Dec 31, 2018 | 600.90M | -24.61% |
Dec 29, 2017 | 797.10M | -34.91% |
Dec 30, 2016 | 1.22B | -11.41% |
Dec 31, 2015 | 1.38B | 535.59% |
Dec 31, 2014 | 217.50M | 21.92% |
Feb 12, 2014 | 178.40M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HeartBeam | 76.09M |
MDxHealth | 76.00M |
enVVeno Medical | 75.85M |
Allakos | 75.26M |
Gritstone bio | 75.17M |
Spero Therapeutics | 74.50M |
Ovid Therapeutics | 74.49M |
Genelux | 74.20M |